Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2019
DSP-01 Barriers to the diagnosis of motor neuron disease - a South Australian studyDale F Sharrad, David W SchultzJournal of the Neurological Sciences|October 27, 2019
Factors contributing to delays in the diagnosis of motor neuron disease - A South Australian studyDale F Sharrad, David W SchultzBrain Communications|November 10, 2023
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerationsMary-Louise Rogers, David W Schultz, Vassilios Karnaros, et al.Plos One|January 30, 2014
The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosisStephanie R Shepheard, Tim Chataway, David W Schultz, et al.AAPS Pharmscitech|April 21, 2019
The Influence of Electrostatic Controls on MDI Size Distribution MeasurementsStephen W Stein, Jack Rasmussen, Sheila Walls, et al.European Journal of Neurology|December 30, 2021
Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosisStephanie R Shepheard, Vassilios Karnaros, Beben Benyamin, et al.The Medical Journal of Australia|April 28, 2017
Motor neurone disease: progress and challengesThanuja Dharmadasa, Robert D Henderson, Paul S Talman, et al.Stroke|December 4, 2010
EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-RegistrationYoshinari Nagakane, Soren Christensen, Caspar Brekenfeld, et al.Pageof 1